Get started
Author

Ashis Samuel John

Observed names: A John, Adole Inalegwu John
ORCID: 0009-0006-1594-0224
Observed ORCID: 0009-0006-1594-0224
OpenAlex ID: A5060049653
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 45
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 42
PDF
Community Based Management of COVID-19 as a Way Forward for Pandemic Response
2021 · Sunil Kumar Panigrahi, Sagarika Majumdar, et al. · Frontiers in Public Health · 16
PDF
Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial
2025 · Ashis Samuel John, Sanjay Ganapathi, et al. · Global Heart · 5
PDF
Patients’ knowledge of prescribed medication: a cross sectional study in a tertiary care centre, Mumbai
2019 · Ashis Samuel John, Kamaxi M. Bhate · International Journal of Community Medicine and Public Health · 1
PDF
Correction: Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial
2025 · Ashis Samuel John, Sanjay Ganapathi, et al. · Global Heart
PDF
Assessment of Knowledge of Covid-19 and Vaccine Hesitancy among Undergraduate Students of University of Jos, Plateau State, Nigeria
2024 · Enefola Emmanuel Ojochide, Adole Inalegwu John, et al. · African Journal of Human Kinetics Recreation and Health Studies
Works count: 8
Citation count: 154
H-index: 5
I10-index: 4
Year
Topic
Type